{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T12:45:43Z","timestamp":1795005943607,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19998-1","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:05:58Z","timestamp":1760526358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Gut dysbiosis in multiple sclerosis patients: a comparative analysis in fecal samples"],"prefix":"10.1038","volume":"15","author":[{"given":"Pegah","family":"Rasoulian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camellia","family":"Akhgarjand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirad","family":"Houjaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homa","family":"Seyedmirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrangiz","family":"Zangeneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khashayar","family":"Danandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Goodarzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima Mohsenzadeh","family":"Kermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"14","key":"19998_CR1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton, C. et al. Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS. Multiple Scler. J. 26 (14), 1816\u20131821 (2020).","journal-title":"Multiple Scler. J."},{"issue":"1","key":"19998_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M. & Bar-Or, A. Piehl Fet al. Multiple Scler. Nat. Rev. Dis. Primers. 4 (1), 43 (2018).","journal-title":"Multiple Scler. Nat. Rev. Dis. Primers"},{"issue":"8","key":"19998_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41582-022-00675-0","volume":"18","author":"J Oh","year":"2022","unstructured":"Oh, J. & Bar-Or, A. Emerging therapies to target CNS pathophysiology in multiple sclerosis. Nat. Reviews Neurol. 18 (8), 466\u2013475 (2022).","journal-title":"Nat. Reviews Neurol."},{"issue":"1","key":"19998_CR4","first-page":"1","volume":"19","author":"N Ghasemi","year":"2017","unstructured":"Ghasemi, N., Razavi, S. & Nikzad, E. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell. J. (Yakhteh). 19 (1), 1 (2017).","journal-title":"Cell. J. (Yakhteh)"},{"issue":"3","key":"19998_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1212\/WNL.0000000000001718","volume":"85","author":"RA Marrie","year":"2015","unstructured":"Marrie, R. A. et al. Effect of comorbidity on mortality in multiple sclerosis. Neurology 85 (3), 240\u2013247 (2015).","journal-title":"Neurology"},{"issue":"18","key":"19998_CR6","doi-asserted-by":"publisher","first-page":"e1810","DOI":"10.1212\/WNL.0000000000200150","volume":"98","author":"B Bebo","year":"2022","unstructured":"Bebo, B. et al. The economic burden of multiple sclerosis in the united States. Neurology 98 (18), e1810\u2013e7 (2022).","journal-title":"Neurology"},{"issue":"2","key":"19998_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","volume":"11","author":"DH Miller","year":"2012","unstructured":"Miller, D. H., Chard, D. T. & Ciccarelli, O. Clinically isolated syndromes. Lancet Neurol. 11 (2), 157\u2013169 (2012).","journal-title":"Lancet Neurol."},{"issue":"3","key":"19998_CR8","first-page":"69","volume":"6","author":"TO Kirby","year":"2018","unstructured":"Kirby, T. O. & Ochoa-Rep\u00e1raz, J. The gut Microbiome in multiple sclerosis: a potential therapeutic avenue. Med. Sci. 6 (3), 69 (2018).","journal-title":"Med. Sci."},{"issue":"40","key":"19998_CR9","doi-asserted-by":"publisher","first-page":"10719","DOI":"10.1073\/pnas.1711233114","volume":"114","author":"K Berer","year":"2017","unstructured":"Berer, K. et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc. Natl. Acad. Sci. 114 (40), 10719\u201310724 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"19998_CR10","first-page":"8168717","volume":"2018","author":"F Chu","year":"2018","unstructured":"Chu, F. et al. Gut microbiota in multiple sclerosis and experimental autoimmune encephalomyelitis: current applications and future perspectives. Mediat. Inflamm. 2018 (1), 8168717 (2018).","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"19998_CR11","doi-asserted-by":"publisher","first-page":"12015","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi, S. et al. Alterations of the human gut Microbiome in multiple sclerosis. Nat. Commun. 7 (1), 12015 (2016).","journal-title":"Nat. Commun."},{"key":"19998_CR12","doi-asserted-by":"crossref","unstructured":"Cekanaviciute, E. et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proceedings of the National Academy of Sciences. ;114(40):10713-8. (2017).","DOI":"10.1073\/pnas.1716911114"},{"key":"19998_CR13","doi-asserted-by":"publisher","first-page":"101427","DOI":"10.1016\/j.msard.2019.101427","volume":"37","author":"A Mirza","year":"2020","unstructured":"Mirza, A. et al. The multiple sclerosis gut microbiota: A systematic review. Multiple Scler. Relat. Disorders. 37, 101427 (2020).","journal-title":"Multiple Scler. Relat. Disorders"},{"issue":"5","key":"19998_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/mi.2010.29","volume":"3","author":"J Ochoa-Rep\u00e1raz","year":"2010","unstructured":"Ochoa-Rep\u00e1raz, J. et al. A polysaccharide from the human commensal bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 3 (5), 487\u2013495 (2010).","journal-title":"Mucosal Immunol."},{"issue":"43","key":"19998_CR15","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol, H. et al. Faecalibacterium Prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. 105 (43), 16731\u201316736 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"19998_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-022-00697-8","volume":"18","author":"J Correale","year":"2022","unstructured":"Correale, J., Hohlfeld, R. & Baranzini, S. E. The role of the gut microbiota in multiple sclerosis. Nat. Reviews Neurol. 18 (9), 544\u2013558 (2022).","journal-title":"Nat. Reviews Neurol."},{"key":"19998_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3325\/cmj.2009.50.105","volume":"50","author":"K Krleza-Jeric","year":"2009","unstructured":"Krleza-Jeric, K. & Lemmens, T. 7th revision of the declaration of helsinki: good news for the transparency of clinical trials. Croatian Med. J. 50, 105\u2013110 (2009).","journal-title":"Croatian Med. J."},{"issue":"2","key":"19998_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17 (2), 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"19998_CR19","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3389\/fmicb.2016.01920","volume":"7","author":"MR Whitaker","year":"2016","unstructured":"Whitaker, M. R., Salzman, S., Sanders, J., Kaltenpoth, M. & Pierce, N. E. Microbial communities of Lycaenid butterflies do not correlate with larval diet. Front. Microbiol. 7, 1920 (2016).","journal-title":"Front. Microbiol."},{"issue":"1","key":"19998_CR20","doi-asserted-by":"publisher","first-page":"e53086","DOI":"10.1371\/journal.pone.0053086","volume":"8","author":"N Shintani","year":"2013","unstructured":"Shintani, N., Siebenrock, K. A. & Hunziker, E. B. TGF-ss1 enhances the BMP-2-induced chondrogenesis of bovine synovial explants and arrests downstream differentiation at an early stage of hypertrophy. PloS One. 8 (1), e53086 (2013).","journal-title":"PloS One"},{"issue":"11","key":"19998_CR21","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1128\/AEM.68.11.5445-5451.2002","volume":"68","author":"T Matsuki","year":"2002","unstructured":"Matsuki, T. et al. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl. Environ. Microbiol. 68 (11), 5445\u20135451 (2002).","journal-title":"Appl. Environ. Microbiol."},{"issue":"1","key":"19998_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1099\/00221287-148-1-257","volume":"148","author":"MA Nadkarni","year":"2002","unstructured":"Nadkarni, M. A., Martin, F. E., Jacques, N. A. & Hunter, N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148 (1), 257\u2013266 (2002).","journal-title":"Microbiology"},{"issue":"6","key":"19998_CR23","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/j.1365-2672.2004.02409.x","volume":"97","author":"T Rinttil\u00e4","year":"2004","unstructured":"Rinttil\u00e4, T., Kassinen, A., Malinen, E., Krogius, L. & Palva, A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and Indigenous bacteria in faecal samples by real\u2010time PCR. J. Appl. Microbiol. 97 (6), 1166\u20131177 (2004).","journal-title":"J. Appl. Microbiol."},{"issue":"3","key":"19998_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/ana.24901","volume":"81","author":"H Tremlett","year":"2017","unstructured":"Tremlett, H., Bauer, K. C., Appel-Cresswell, S., Finlay, B. B. & Waubant, E. The gut Microbiome in human neurological disease: a review. Ann. Neurol. 81 (3), 369\u2013382 (2017).","journal-title":"Ann. Neurol."},{"issue":"7","key":"19998_CR25","doi-asserted-by":"publisher","first-page":"e1700492","DOI":"10.1126\/sciadv.1700492","volume":"3","author":"I Cosorich","year":"2017","unstructured":"Cosorich, I. et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci. Adv. 3 (7), e1700492 (2017).","journal-title":"Sci. Adv."},{"key":"19998_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12016-011-8291-x","volume":"42","author":"A Fasano","year":"2012","unstructured":"Fasano, A. Leaky gut and autoimmune diseases. Clin. Rev. Allergy Immunol. 42, 71\u201378 (2012).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"19998_CR27","unstructured":"Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. (2019)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19998-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19998-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19998-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:06:00Z","timestamp":1760526360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19998-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19998"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19998-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36009"}}